Cover Image
市場調查報告書

NuCana BioMed Limited:產品平台分析

NuCana BioMed Limited - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 308914
出版日期 內容資訊 英文 32 Pages
訂單完成後即時交付
價格
Back to Top
NuCana BioMed Limited:產品平台分析 NuCana BioMed Limited - Product Pipeline Review - 2015
出版日期: 2015年08月31日 內容資訊: 英文 32 Pages
簡介

NuCana BioMed Limited 是總公司設置於英國愛丁堡,致力於基於ProTide技術平台來開發新癌症治療藥的生物製藥公司。

本報告提供NuCana BioMed Limited的治療藥開發平台的現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,後期階段及中止的計劃等相關資訊。

NuCana BioMed Limited的基本資料

  • NuCana BioMed Limited概要
  • 主要資訊
  • 企業資料

NuCana BioMed Limited:R&D概要

  • 主要的治療範圍

NuCana BioMed Limited:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

NuCana BioMed Limited:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第Ⅱ期的產品/聯合治療模式
    • 第Ⅰ期的產品/聯合治療模式
  • 初期階段的開發中產品
    • IND/CTA 所申請的產品/聯合治療模式
    • 前臨床階段的產品/聯合治療模式

NuCana BioMed Limited:藥物簡介

  • NUC-1031
  • NUC-3373
  • NUC-7738
  • NUC-4545
  • NUC-5435
  • NUC-6285
  • NUC-9000
  • NUC-9324

NuCana BioMed Limited:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

NuCana BioMed Limited:最近的開發平台趨勢

NuCana BioMed Limited:暫停中的計劃

NuCana BioMed Limited:總公司和子公司的所在地

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07415CDB

Summary

Global Markets Direct's, 'NuCana BioMed Limited - Product Pipeline Review - 2015', provides an overview of the NuCana BioMed Limited's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of NuCana BioMed Limited's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of NuCana BioMed Limited including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of NuCana BioMed Limited's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the NuCana BioMed Limited's pipeline products

Reasons to buy

  • Evaluate NuCana BioMed Limited's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of NuCana BioMed Limited in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the NuCana BioMed Limited's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of NuCana BioMed Limited and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of NuCana BioMed Limited
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of NuCana BioMed Limited and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • NuCana BioMed Limited Snapshot
    • NuCana BioMed Limited Overview
    • Key Information
    • Key Facts
  • NuCana BioMed Limited - Research and Development Overview
    • Key Therapeutic Areas
  • NuCana BioMed Limited - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • NuCana BioMed Limited - Pipeline Products Glance
    • NuCana BioMed Limited - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • NuCana BioMed Limited - Early Stage Pipeline Products
      • IND/CTA Filed Products/Combination Treatment Modalities
      • Preclinical Products/Combination Treatment Modalities
  • NuCana BioMed Limited - Drug Profiles
    • NUC-1031
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NUC-3373
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NUC-7738
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NUC-4545
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NUC-5435
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NUC-6285
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NUC-9000
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NUC-9324
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • NuCana BioMed Limited - Pipeline Analysis
    • NuCana BioMed Limited - Pipeline Products by Target
    • NuCana BioMed Limited - Pipeline Products by Route of Administration
    • NuCana BioMed Limited - Pipeline Products by Molecule Type
    • NuCana BioMed Limited - Pipeline Products by Mechanism of Action
  • NuCana BioMed Limited - Recent Pipeline Updates
  • NuCana BioMed Limited - Dormant Projects
  • NuCana BioMed Limited - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • NuCana BioMed Limited, Key Information
  • NuCana BioMed Limited, Key Facts
  • NuCana BioMed Limited - Pipeline by Indication, 2015
  • NuCana BioMed Limited - Pipeline by Stage of Development, 2015
  • NuCana BioMed Limited - Monotherapy Products in Pipeline, 2015
  • NuCana BioMed Limited - Phase II, 2015
  • NuCana BioMed Limited - Phase I, 2015
  • NuCana BioMed Limited - IND/CTA Filed, 2015
  • NuCana BioMed Limited - Preclinical, 2015
  • NuCana BioMed Limited - Pipeline by Target, 2015
  • NuCana BioMed Limited - Pipeline by Route of Administration, 2015
  • NuCana BioMed Limited - Pipeline by Molecule Type, 2015
  • NuCana BioMed Limited - Pipeline Products by Mechanism of Action, 2015
  • NuCana BioMed Limited - Recent Pipeline Updates, 2015
  • NuCana BioMed Limited - Dormant Developmental Projects,2015

List of Figures

  • NuCana BioMed Limited - Pipeline by Top 10 Indication, 2015
  • NuCana BioMed Limited - Pipeline by Stage of Development, 2015
  • NuCana BioMed Limited - Monotherapy Products in Pipeline, 2015
  • NuCana BioMed Limited - Pipeline by Top 10 Target, 2015
  • NuCana BioMed Limited - Pipeline by Top 10 Route of Administration, 2015
  • NuCana BioMed Limited - Pipeline by Top 10 Molecule Type, 2015
  • NuCana BioMed Limited - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top